Chemical formula: C₂₉H₂₃F₆N₅O₃  Molecular mass: 603.516 g/mol  PubChem compound: 72163100

Therapeutic indications

Atogepant is indicated for:


Population group: only adults (18 years old or older)

Atogepant is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.

For this indication, competent medicine agencies globally authorize below treatments (click for details):


Atogepant is contraindicated in the following cases:



Severe hepatic impairment

Hepatic failure stage IV

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.